Sign inSubscribe

target directory

acute ischemic stroke clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.

Validated reports

1

Directory type

target

Association rule

normalized field

NCT05225961
Source recordAI-normalized

Randomized Multi-center Clinical Trial to Assess Effectiveness and Safety of Tirofiban Versus Intravenous Aspirin in Patients With Acute Ischemic Stroke Secondary to Tandem Injury, Subject to Recanalization Therapy Through Endovascular Treatment

The ATILA trial evaluates the effectiveness and safety of Tirofiban versus intravenous Aspirin in patients with acute ischemic stroke due to tandem lesions, undergoing endovascular treatment. This study aims to establish a protocol for antiplatelet therapy in this patient population, potentially leading to improved outcomes and reduced complications.

AI analysis

Indication: Acute Ischemic Stroke

Modality: small molecule

Target: Acute Ischemic Stroke

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Source URL: ClinicalTrials.gov

Source updated: Apr 03, 2026

Ingested: May 23, 2026

Model: trialsignal-ai-v1

Validation: validated

Matched by target_normalized: Acute Ischemic Stroke

View original source fields

Condition raw: Acute Ischemic Stroke

Condition normalized: Acute Ischemic Stroke

Modality raw: Acute Ischemic Stroke

Modality normalized: small molecule

Target raw: Acute Ischemic Stroke

Target normalized: Acute Ischemic Stroke

Open report